Table 1.
Clinical characteristics of included and excluded patients
| Included (n = 174 | Excluded (n = 33) | ||
|---|---|---|---|
| n (%) | n (%) | P value | |
| Age, years, mean ± SD | 39.1 ± 16 | 37.7 ± 16.6 | 0.646 |
| Female sex | 80 (46) | 16 (48.5) | 0.881 |
| Race* | 0.497 | ||
| Asian | 104 (59.8) | 20 (60.6) | |
| White | 63 (36.2) | 11 (33.3) | |
| African American | 4 (2.3) | 2 (6.1) | |
| Unknown | 3 (1.7) | 0 | |
| Hispanic | 55 (31.6) | 7 (21.2) | 0.225 |
| Prior anti-tuberculosis treatment | 46 (26.4) | 12 (36.4) | 0.325 |
| HIV infection* | 5 (2.9) | 0 | 0.380 |
| Diabetes mellitus* | 7 (4) | 1 (3) | 0.786 |
| BCG vaccination | 33 (19) | 5 (15.2) | 0.604 |
| Homeless in last 12 months* | 7 (4) | 0 | 0.602 |
| Correctional facility at time of diagnosis* | 5 (2.9) | 3 (9.1) | 0.113 |
| Long-term facility at time of diagnosis* | 2 (1.1) | 1 (3) | 0.392 |
| Injecting drug user in last 12 months* | 2 (1.1) | 0 | 1.000 |
| Excessive alcohol use in last 12 months* | 22 (12.6) | 4 (12.1) | 1.000 |
*
As expected cell counts were <5, P value was calculated using Fisher’s exact test.
SD = standard deviation; HIV = human immunodeficiency virus; BCG = bacille Calmette-Guérin.